# CytosinLab Therapeutics Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cytosinlab-therapeutics-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.cytosinlab.com
- Total disclosed funding: $45M
- Latest round: Series A (Dec 25, 2023)
- Investors on record: 8

## About

Established in 2019 and based in Shenzhen, China, CytosinLab Therapeutics Co., Ltd. operates as a biomedical company that focuses on the research and development of new drugs for major diseases such as cancer. The company's founding team includes academicians from the Chinese Academy of Sciences, pharmaceutical companies. Several academic institutions, such as Shanghai Institute of Chinese Academy of Sciences, Fudan University, and Jiaotong University, have cooperated with the company. It has set up a R&D center in Shanghai and a branch office in Shenzhen. In December 2023, CytosinLab raised approximately CNY 100 million in series A+ funding.

CytosinLab built a EpigenPlus platform that uses for targeting epigenetic therapeutic targets and epigenetic regulatory mechanisms, including tumor mismatch repair mechanisms, tumor differentiation mechanisms, and tumor metabolism mechanisms. The company has also developed innovative drugs CTS2190 and CTS2016, which can be used to treat hematological and solid tumors.

Its PRMT5-MTA complex inhibitor will also be in clinical Phase I trials in 2024.

## Funding rounds

- Series A, Dec 25, 2023, $14M — Fortune Capital, Heda Venture
- Series A, Jan 4, 2022, $31M — CDH Investments, Kaitai Capital, SAIC Capital, Lake Ventures, Dawu Venture
- Angel, Apr 26, 2020 — Shenzhen Capital Real Estate Fund

## Investors

- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Angel
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series A
- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Series A
- SAIC Capital (https://capitalatlas.ai/funds/saic-capital) — Series A
- Lake Ventures — Series A
- Dawu Venture — Series A
- Fortune Capital — Series A
- Heda Venture (https://capitalatlas.ai/funds/heda-venture) — Series A